Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade
KAUR G. et al, (2022), Nature Communications
Identification of early neurodegenerative pathways in progressive multiple sclerosis
Kaufmann M. et al, (2022), Nature Neuroscience
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis
Kaufmann M. et al, (2021), Med, 2, 296 - 312.e8
Structural and regulatory diversity shape HLA-C protein expression levels
Kaur G. et al, (2017), Nature Communications, 8
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity
Dendrou CA. et al, (2016), Science Translational Medicine, 8
Natural killer cells and their receptors in multiple sclerosis
Kaur G. et al, (2013), Brain, 136, 2657 - 2676
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory AP. et al, (2012), Nature, 488, 508 - 511
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells—Identification of Foxp3Δ7 in human regulatory T cells
Kaur G. et al, (2010), Molecular Immunology, 48, 321 - 332
The role of Foxp3 in regulatory T cell differentiation and function
Kaur G. et al, (2009), Current Immunology Reviews, 5, 89 - 101
A role of cellular prion protein in programming T‐cell cytokine responses in disease
Ingram RJ. et al, (2009), The FASEB Journal, 23, 1672 - 1684
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells.
Isaacs JD. et al, (2008), Immunology, 125, 313 - 319
CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Duggleby RC. et al, (2007), Immunology, 121, 129 - 139